Φορτώνει......
Ligandomics: a paradigm shift in biological drug discovery
As productivity of pharmaceutical research and development (R&D) for small-molecule drugs declines, the trend in drug discovery strategies is shifting towards biologics, which predominantly target secreted or cell surface proteins. Receptors and ligands are the most-valuable drug targets. In con...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Drug Discov Today |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849512/ https://ncbi.nlm.nih.gov/pubmed/29326083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.01.013 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|